- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Stage III Prostate Cancer in Belgium
Total 246 results
-
Advanced Medical Diagnostics s.a.CompletedProstate CancerGermany, United Kingdom, Belgium, Czech Republic, Hungary
-
UMC UtrechtCompletedMRI | Prostate Cancer | RadiotherapyBelgium, Netherlands
-
Universitaire Ziekenhuizen KU LeuvenUnknown
-
Universitair Ziekenhuis BrusselRIZIVCompletedMalignant Melanoma Stage III | Malignant Melanoma Stage IVBelgium
-
Centocor, Inc.TerminatedCancer, ProstateUnited States, United Kingdom, Belgium, Germany, Spain, France, Austria
-
Universitaire Ziekenhuizen KU LeuvenAZ Sint-Jan AV; General Hospital Groeninge; AZ Sint-Blasius DendermondeRecruitingProstate Cancer | Adenocarcinoma of the Prostate | Locally Advanced Prostate Carcinoma | Locally Advanced Prostate AdenocarcinomaBelgium
-
Epizyme, Inc.Active, not recruitingMetastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Spain, Belgium
-
Novosanis NVUniversiteit AntwerpenWithdrawnProstate Cancer | Urine | Liquid BiopsyBelgium
-
Cliniques universitaires Saint-Luc- Université...CompletedProstate Cancer | Primary DiseaseFrance, Belgium
-
Universitaire Ziekenhuizen KU LeuvenIpsenRecruiting
-
Astellas Pharma IncMedivation, Inc.CompletedProstate CancerBelgium, Czechia, Denmark, Germany
-
IpsenTerminatedMetastatic Castrate Resistant Prostate CancerFrance, Spain, Poland, Belgium, Germany, Italy, Denmark, Lithuania, United Kingdom, Czechia, Hungary
-
UNICANCERBayerRecruitingProstate Cancer MetastaticSpain, France, Ireland, Belgium
-
Universitaire Ziekenhuizen KU LeuvenRecruitingProstate Cancer | Radiotherapy | SBRTBelgium
-
RhoVac APSActive, not recruitingProstate Cancer RecurrentSweden, United States, Finland, United Kingdom, Belgium, Germany, Denmark
-
Karolinska InstitutetThe Swedish Research Council; AstraZeneca; Janssen Pharmaceutica N.V., Belgium; Kom Op Tegen Kanker and other collaboratorsRecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC) | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)Sweden, Belgium, Switzerland, Norway
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedMetastatic Hormone Refractory Prostate CancerUnited States, France, Spain, Belgium, Singapore, Italy, Australia, Germany
-
EMD SeronoCompletedProstate Cancer MetastaticUnited States, Australia, France, Poland, Russian Federation, Spain, Germany, Netherlands, Slovakia, Canada, South Africa, Belgium
-
Leiden University Medical CenterJessa Hospital; The Netherlands Cancer InstituteRecruitingImmunotherapy | Non Small Cell Lung Cancer Stage IIINetherlands, Belgium
-
Janssen Research & Development, LLCCompletedMetastatic Breast Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Belgium, Spain, Germany, Sweden, Australia, United Kingdom
-
Cliniques universitaires Saint-Luc- Université...Ferring PharmaceuticalsUnknown
-
Astellas Pharma Europe B.V.Medivation, Inc.CompletedMetastatic Castration-Resistant Prostate CancerBelgium, France, Germany, Spain, United Kingdom
-
SanofiCompletedProstate Cancer MetastaticUnited Kingdom, Austria, Belgium, Czechia, France, Germany, Greece, Iceland, Ireland, Italy, Netherlands, Norway, Spain
-
Hasselt UniversityZiekenhuis Oost-LimburgCompleted
-
Astellas Pharma IncCompleted
-
Bracco Diagnostics, IncBracco Imaging S.p.A.TerminatedProstate CancerItaly, Austria, France, Netherlands, Belgium, Germany, United Kingdom
-
Radboud University Medical CenterJohns Hopkins University; University Health Network, Toronto; Medical University... and other collaboratorsCompletedProstate CancerUnited States, Austria, Belgium, Canada, Germany, Netherlands, Norway, United Kingdom
-
Astellas Pharma IncAstellas Pharma US, Inc.TerminatedProstatic Neoplasms | Hormone-Refractory Prostate CancerUnited States, Ireland, Australia, France, United Kingdom, Belgium, Germany, Netherlands, Poland, Spain
-
SanofiCompletedProstate Cancer MetastaticAustralia, Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czech Republic, Denmark, Finland, Hungary, India, Ireland, Italy, Kazakhstan, Luxembourg, Malaysia, Mexico, Philippines, Poland, Portugal, Romania, Serbia, Singapo... and more
-
AstraZenecaParexelCompletedProgressive Metastatic Castrate-Resistant Prostate CancerUnited States, Spain, Belgium, France, Korea, Republic of
-
AstraZenecaCompletedNon-Metastatic Prostate CancerCzech Republic, Italy, South Africa, United Kingdom, Germany, Poland, Netherlands, Austria, Belgium, Hungary, Israel, Portugal, Mexico, Spain, Australia, Ireland
-
Ferring PharmaceuticalsCompleted
-
AmgenActive, not recruitingNeuroendocrine Prostate CancerBelgium, United States, Austria, Spain, Australia, Netherlands, France, United Kingdom, Japan
-
University GhentUniversity Hospital, GenevaActive, not recruitingProstate Cancer | Metastatic Cancer | Prostate Cancer Metastatic | Oligometastatic CancerNorway, Spain, Belgium, Switzerland, Australia, Italy
-
European Organisation for Research and Treatment...CompletedProstate CancerNetherlands, Belgium, Israel, Malta, Russian Federation, Turkey, United Kingdom
-
European Organisation for Research and Treatment...CompletedProstate CancerFrance, Spain, Belgium, Switzerland, Israel, Germany
-
Bavarian NordicCompletedProstate Cancer MetastaticUnited States, Spain, Germany, Netherlands, Belgium, United Kingdom, Australia, Denmark, France, Canada, Israel, Russian Federation, Puerto Rico, Estonia, Poland, Iceland
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)Korea, Republic of, United States, Spain, France, Belgium, China, Taiwan, United Kingdom, Australia, Czechia, Hungary, Poland, Russian Federation
-
MacroGenicsRecruitingProstate Cancer Recurrent | Immunotherapy | Androgen-Independent Prostatic Cancer | Androgen-Resistant Prostatic Cancer | Hormone Refractory Prostatic Cancer | Immune Checkpoint Inhibitor | Androgen-Independent Prostatic Neoplasms | Androgen-Insensitive Prostatic Cance | Inhibitory Checkpoint MoleculeUnited States, Spain, France, Belgium, United Kingdom, Poland, Georgia, Bulgaria, Puerto Rico, Australia
-
AgennixCompletedProstate Cancer | Hormone Refractory Prostate CancerUnited States, United Kingdom, France, Italy, Israel, Germany, Hungary, Argentina, Russian Federation, Belgium, Croatia, Netherlands, Peru, Poland, Spain
-
Centocor Research & Development, Inc.CompletedProstate CancerUnited States, United Kingdom, Belgium, Russian Federation
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration-Resistant Prostate CancerUnited States, Canada, France, Spain, United Kingdom, Australia, Poland, Germany, Austria, Belgium, Netherlands, Italy, Chile, South Africa, Argentina
-
Ferring PharmaceuticalsCompletedProstate CancerBelgium, Germany, Hungary, Netherlands, Romania, Russian Federation, South Africa
-
Cancer Research AntwerpBayer; Veracyte, Inc.Recruiting
-
Astellas Pharma IncAstellas Pharma US, Inc.TerminatedProstate CancerBelgium, Czech Republic, France, Germany, Poland, Spain, United Kingdom
-
Ferring PharmaceuticalsCompletedProstate CancerFinland, Belgium, Netherlands, Russian Federation, Germany, Romania, United Kingdom, France, Montenegro, Serbia
-
SOTIO a.s.CompletedMetastatic Castration-resistant Prostate CancerUnited States, Spain, United Kingdom, Germany, Serbia, Portugal, Lithuania, Slovakia, Hungary, Netherlands, Croatia, France, Czechia, Poland, Austria, Belarus, Belgium, Bulgaria, Denmark, Italy, Latvia, Sweden
-
European Organisation for Research and Treatment...CompletedProstate Cancer | Metastatic CancerNetherlands, Denmark, Belgium, Poland, Switzerland, United Kingdom, Italy, Russian Federation, Portugal
-
European Organisation for Research and Treatment...CompletedProstate CancerBelgium, Italy, France, Netherlands, United Kingdom, Poland, Ireland, Spain, Cyprus, Czech Republic, Luxembourg